Blueprint Medicines Statistics
Total Valuation
| Market Cap | n/a |
| Enterprise Value | n/a |
Important Dates
The last earnings date was Thursday, July 31, 2025, before market open.
| Earnings Date | Jul 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +4.21% |
| Shares Change (QoQ) | +4.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 60.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 10.55 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.80, with a Debt / Equity ratio of 2.08.
| Current Ratio | 2.80 |
| Quick Ratio | 2.62 |
| Debt / Equity | 2.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.73 |
| Interest Coverage | -2.44 |
Financial Efficiency
Return on equity (ROE) is -47.71% and return on invested capital (ROIC) is -11.09%.
| Return on Equity (ROE) | -47.71% |
| Return on Assets (ROA) | -9.75% |
| Return on Invested Capital (ROIC) | -11.09% |
| Return on Capital Employed (ROCE) | -18.44% |
| Revenue Per Employee | $820,615 |
| Profits Per Employee | -$227,342 |
| Employee Count | 649 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.90 |
Taxes
In the past 12 months, BPMC has paid $1.84 million in taxes.
| Income Tax | 1.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +13.20% in the last 52 weeks. The beta is 0.83, so BPMC's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +13.20% |
| 50-Day Moving Average | 118.77 |
| 200-Day Moving Average | 99.62 |
| Relative Strength Index (RSI) | 76.66 |
| Average Volume (20 Days) | 4,293,319 |
Short Selling Information
The latest short interest is 3.68 million, so 5.69% of the outstanding shares have been sold short.
| Short Interest | 3.68M |
| Short Previous Month | 3.13M |
| Short % of Shares Out | 5.69% |
| Short % of Float | 6.12% |
| Short Ratio (days to cover) | 0.93 |
Income Statement
In the last 12 months, BPMC had revenue of $562.12 million and -$155.73 million in losses. Loss per share was -$2.45.
| Revenue | 562.12M |
| Gross Profit | 542.35M |
| Operating Income | -174.31M |
| Pretax Income | -153.89M |
| Net Income | -155.73M |
| EBITDA | -158.37M |
| EBIT | -174.31M |
| Loss Per Share | -$2.45 |
Balance Sheet
The company has $576.24 million in cash and $713.33 million in debt, giving a net cash position of $186.45 million.
| Cash & Cash Equivalents | 576.24M |
| Total Debt | 713.33M |
| Net Cash | 186.45M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 342.13M |
| Book Value Per Share | 5.30 |
| Working Capital | 451.49M |
Cash Flow
In the last 12 months, operating cash flow was -$145.55 million and capital expenditures -$5.36 million, giving a free cash flow of -$150.91 million.
| Operating Cash Flow | -145.55M |
| Capital Expenditures | -5.36M |
| Free Cash Flow | -150.91M |
| FCF Per Share | n/a |
Margins
Gross margin is 96.48%, with operating and profit margins of -31.01% and -27.70%.
| Gross Margin | 96.48% |
| Operating Margin | -31.01% |
| Pretax Margin | -27.38% |
| Profit Margin | -27.70% |
| EBITDA Margin | -28.17% |
| EBIT Margin | -31.01% |
| FCF Margin | n/a |
Dividends & Yields
BPMC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.21% |
| Shareholder Yield | -4.21% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for BPMC is $128.87, which is -0.46% lower than the current price. The consensus rating is "Buy".
| Price Target | $128.87 |
| Price Target Difference | -0.46% |
| Analyst Consensus | Buy |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | 26.76% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BPMC has an Altman Z-Score of 1.93 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.93 |
| Piotroski F-Score | 3 |